IS6724A - Aðferð til framleiðslu á N-arýl-anþranilískum sýrum og afleiðum þeirra - Google Patents

Aðferð til framleiðslu á N-arýl-anþranilískum sýrum og afleiðum þeirra

Info

Publication number
IS6724A
IS6724A IS6724A IS6724A IS6724A IS 6724 A IS6724 A IS 6724A IS 6724 A IS6724 A IS 6724A IS 6724 A IS6724 A IS 6724A IS 6724 A IS6724 A IS 6724A
Authority
IS
Iceland
Prior art keywords
aryl
derivatives
preparation
anthranilic acids
anthranilic
Prior art date
Application number
IS6724A
Other languages
English (en)
Icelandic (is)
Inventor
Huai Gu Chen Michael
Mark Davis Edward
Magano Javier
Norman Nanninga Thomas
Dale Winkle Derick
Original Assignee
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc
Publication of IS6724A publication Critical patent/IS6724A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/10Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
IS6724A 2000-08-25 2003-02-20 Aðferð til framleiðslu á N-arýl-anþranilískum sýrum og afleiðum þeirra IS6724A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22820600P 2000-08-25 2000-08-25
PCT/US2001/022948 WO2002018319A1 (en) 2000-08-25 2001-07-20 Process for making n-aryl-anthranilic acids and their derivatives

Publications (1)

Publication Number Publication Date
IS6724A true IS6724A (is) 2003-02-20

Family

ID=22856235

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6724A IS6724A (is) 2000-08-25 2003-02-20 Aðferð til framleiðslu á N-arýl-anþranilískum sýrum og afleiðum þeirra

Country Status (31)

Country Link
EP (1) EP1313694A1 (de)
JP (1) JP2004507518A (de)
KR (1) KR20030059115A (de)
CN (1) CN1458921A (de)
AP (1) AP2001002249A0 (de)
AR (1) AR032175A1 (de)
AU (1) AU2001277044A1 (de)
BG (1) BG107635A (de)
BR (1) BR0113520A (de)
CA (1) CA2420003A1 (de)
CZ (1) CZ2003477A3 (de)
DO (1) DOP2001000238A (de)
EA (1) EA200300187A1 (de)
GT (1) GT200100174A (de)
HN (1) HN2001000216A (de)
HU (1) HUP0300828A2 (de)
IL (1) IL154507A0 (de)
IS (1) IS6724A (de)
MA (1) MA26949A1 (de)
MX (1) MXPA03001654A (de)
NO (1) NO20030844L (de)
PA (1) PA8526501A1 (de)
PE (1) PE20020393A1 (de)
PL (1) PL360699A1 (de)
SK (1) SK2072003A3 (de)
SV (1) SV2002000601A (de)
TN (1) TNSN01127A1 (de)
UY (1) UY26908A1 (de)
WO (1) WO2002018319A1 (de)
YU (1) YU14303A (de)
ZA (1) ZA200301182B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL401637A1 (pl) 2002-03-13 2013-05-27 Array Biopharma Inc. N3 alkilowane pochodne benzimidazolu jako inhibitory MEK
US7235537B2 (en) 2002-03-13 2007-06-26 Array Biopharma, Inc. N3 alkylated benzimidazole derivatives as MEK inhibitors
US7144907B2 (en) 2003-09-03 2006-12-05 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
US7538120B2 (en) 2003-09-03 2009-05-26 Array Biopharma Inc. Method of treating inflammatory diseases
EP1682495A1 (de) 2003-10-21 2006-07-26 Warner-Lambert Company LLC Polymorphe form von n-[(r)-2,3-dihydroxypropoxy]-3,4-difluor-2-(2-fluor-4-iodophenylamino)benzamid
WO2005051302A2 (en) 2003-11-19 2005-06-09 Array Biopharma Inc. Bicyclic inhibitors of mek and methods of use thereof
US7732616B2 (en) 2003-11-19 2010-06-08 Array Biopharma Inc. Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
US7517994B2 (en) 2003-11-19 2009-04-14 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
CN1882347A (zh) 2003-11-21 2006-12-20 阿雷生物药品公司 Akt蛋白激酶抑制剂
UA89035C2 (ru) * 2003-12-03 2009-12-25 Лео Фарма А/С Эфиры гидроксамовых кислот и их фармацевтическое применение
ME02051B (me) 2005-04-13 2015-05-20 Astex Therapeutics Ltd Derivati hidroksibenzamida i njihova primena kao inhibitora hsp90
EP1967516B1 (de) 2005-05-18 2009-11-04 Array Biopharma, Inc. 4-(Phenylamino)-6-oxo-1,6-dihydropyridazine-3-carboxamid Derivate als MEK Inhibitoren zur Behandlung von hyperproliferativen Erkrankungen
US7754725B2 (en) 2006-03-01 2010-07-13 Astex Therapeutics Ltd. Dihydroxyphenyl isoindolymethanones
EP2054418B1 (de) 2006-07-06 2011-11-09 Array Biopharma Inc. Dihydrothienopyrimidine als akt-proteinkinase-inhibitoren
BRPI0713555A2 (pt) 2006-07-06 2012-03-20 Array Biopharma, Inc. ciclopenta [d] pirimidinas como inibidores de akt protéina cinase
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
US8329701B2 (en) 2006-07-06 2012-12-11 Array Biopharma Inc. Dihydrofuro pyrimidines as AKT protein kinase inhibitors
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
EP2073807A1 (de) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmazeutische kombinationen
GB0620259D0 (en) 2006-10-12 2006-11-22 Astex Therapeutics Ltd Pharmaceutical compounds
US9730912B2 (en) 2006-10-12 2017-08-15 Astex Therapeutics Limited Pharmaceutical compounds
JP5410285B2 (ja) 2006-10-12 2014-02-05 アステックス、セラピューティックス、リミテッド 医薬化合物
US8277807B2 (en) 2006-10-12 2012-10-02 Astex Therapeutics Limited Pharmaceutical combinations
AU2008272830B8 (en) 2007-07-05 2013-12-12 Array Biopharma Inc. Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
US8846683B2 (en) 2007-07-05 2014-09-30 Array Biopharma, Inc. Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
US9409886B2 (en) 2007-07-05 2016-08-09 Array Biopharma Inc. Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
CA2692506C (en) 2007-07-05 2015-11-24 Array Biopharma Inc. Pyrimidyl cyclopentanes as akt protein kinase inhibitors
MX2010007546A (es) 2008-01-09 2010-09-30 Array Biopharma Inc Pirimidil ciclopentanos hidroxilados en forma de inhibidores de akt proteína quinasa.
NZ586346A (en) 2008-01-09 2012-02-24 Array Biopharma Inc Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
GB0806527D0 (en) 2008-04-11 2008-05-14 Astex Therapeutics Ltd Pharmaceutical compounds
CN101985428B (zh) * 2009-07-29 2014-02-12 杭州民生药业有限公司 邻苯胺基苯甲酸衍生物或其药学上可接受的盐、其制备方法及其用途
EP2536682A1 (de) * 2010-02-19 2012-12-26 Centre National De La Recherche Scientifique Verfahren für die zubereitung von bestimmten chemischen verbindungen mittels nukleophiler aromatischer substitution aromatischer carbonsäurederivate mit mindestens einer elektroattraktiven gruppe
EP2536683A1 (de) * 2010-02-19 2012-12-26 Centre National De La Recherche Scientifique Verfahren für die zubereitung von bestimmten chemischen verbindungen mittels aromatischer nukleophiler substitution
CN103841976A (zh) 2011-04-01 2014-06-04 基因泰克公司 Akt和mek抑制剂化合物的组合及其使用方法
HUE036513T2 (hu) 2011-04-01 2018-07-30 Genentech Inc AKT inhibitor vegyület és abirateron kombinációja terápiás kezelésekben való alkalmazásra
CN104837826B (zh) * 2012-10-12 2018-07-27 埃克塞里艾克西斯公司 制备用于治疗癌症的化合物的新型方法
CN112745237B (zh) * 2019-10-29 2023-06-20 中国科学院上海药物研究所 2-芳基胺类化合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3138636A (en) * 1960-06-23 1964-06-23 Parke Davis & Co Anthranilic acid derivatives
AU5610398A (en) * 1997-02-28 1998-09-18 Warner-Lambert Company Method of treating or preventing septic shock by administering a mek inhibitor
ATE344791T1 (de) * 1997-07-01 2006-11-15 Warner Lambert Co 2-(4-brom or 4-iod phenylamino)benzoesäurederivate und ihre anwendung als mek-inhibitoren
HUP0003731A3 (en) * 1997-07-01 2002-11-28 Warner Lambert Co 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors
CA2348236A1 (en) * 1999-01-13 2000-07-20 Stephen Douglas Barrett 4-arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective mek inhibitors
HUP0200932A3 (en) * 1999-04-21 2002-11-28 Warner Lambert Co Method for making 2-(n-phenylamino)benzoic acids

Also Published As

Publication number Publication date
NO20030844L (no) 2003-02-25
UY26908A1 (es) 2001-11-30
GT200100174A (es) 2002-07-18
NO20030844D0 (no) 2003-02-24
CA2420003A1 (en) 2002-03-07
YU14303A (sh) 2006-08-17
TNSN01127A1 (en) 2005-11-10
PL360699A1 (en) 2004-09-20
EA200300187A1 (ru) 2003-08-28
MA26949A1 (fr) 2004-12-20
HN2001000216A (es) 2002-05-22
JP2004507518A (ja) 2004-03-11
SK2072003A3 (en) 2004-01-08
HUP0300828A2 (hu) 2003-09-29
ZA200301182B (en) 2004-05-12
IL154507A0 (en) 2003-09-17
KR20030059115A (ko) 2003-07-07
AR032175A1 (es) 2003-10-29
WO2002018319A1 (en) 2002-03-07
BG107635A (bg) 2004-09-30
PA8526501A1 (es) 2002-07-30
BR0113520A (pt) 2003-06-24
AP2001002249A0 (en) 2001-09-30
PE20020393A1 (es) 2002-05-09
SV2002000601A (es) 2002-04-03
DOP2001000238A (es) 2003-01-31
AU2001277044A1 (en) 2002-03-13
CZ2003477A3 (cs) 2003-10-15
CN1458921A (zh) 2003-11-26
MXPA03001654A (es) 2004-09-10
EP1313694A1 (de) 2003-05-28

Similar Documents

Publication Publication Date Title
IS6724A (is) Aðferð til framleiðslu á N-arýl-anþranilískum sýrum og afleiðum þeirra
IS2290B (is) Aðferð til framleiðslu á díhýdroxýesterum og afleiðum þeirra
IS2223B (is) Aðferð til framleiðslu á 5-sýanóþalíði
IS2468B (is) Aðferðir og milliefni til framleiðslu á efnasamböndum gegn krabbameini
DK0985697T3 (da) Oxiranderivater og fremgangsmåde til fremstilling deraf
IS5952A (is) Aðferð til framleiðslu á 5-sýanóþalíði
NO20034079D0 (no) Fremgangsmåte for fremstilling av interpolymerer og produkter laget derav
IS6092A (is) Aðferð til framleiðslu á amín platínu komplexum
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
IS6487A (is) Aðferð til framleiðslu á Sítalóprami
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO20031701D0 (no) Fremgangsmåte og mellomprodukter i fremstilling av 7- substituerte antiöstrogener
IS5627A (is) Svefnlyfs ß-karbólín afleiður, aðferð til framleiðslu á þeim og notkun þeirra sem læknislyfja
DK1339723T3 (da) Fremgangsmåde og ester derivater anvendelige til fremstilling af cefalosporiner
DK1341758T3 (da) Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme
NO20030515D0 (no) Fremgangsmåte for fremstilling av dinapsolin
GB2384779B (en) Method for the production of tagged proteins
NO20030587D0 (no) Fremgangsmåte til fremstilling av diskodermolid og analoger derav
IS5212A (is) Bætt aðferð til framleiðslu á pýrazólópýrimidínónafleiðu
NO20011921D0 (no) Sulfidoamidokarboksylsyrer, metoder for fremstilling derav og anvendelser derav
NO20023702D0 (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20014449L (no) Fremgangsmåte for fremstilling av 5-amino-8- alkylkinolonkarboksylsyrederivater og mellomprodukter ifremstillingen derav
NO20023687D0 (no) 1,3,4-oksadiazolderivater og fremgangsmåte for fremstilling derav
IS6615A (is) Aðferð til að búa til sýklóprópýlkarboxýlsýruestera og afleiður
NO20023845L (no) Pluraflaviner og derivater derav, fremgangsmåte for fremstilling av disse og deres anvendelse